Skip to main content

Sequenom Launches MassArray Assay Design and Validation Services

NEW YORK, Sept. 22 (GenomeWeb News) - Sequenom is offering a new assay development and validation service for its MassArray platform, the company said today.


Customers of the company's MassArray system can submit data for a customized assay through a website and are promised to obtain a validated assay within 12 business days.


Sequenom hopes the new service will create a new consumables revenue stream and long-term customer relationships.


For more in-depth information, see an article in this week's Pharmacogenomics Reporter.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.